Analysis on the price and purchase channel safety of Indian version of Sotorashib (AMG 510)

Sotorasib (AMG 510) is a targeted drug targeting KRAS G12C mutation and has clear clinical efficacy. According to the latest information, there is currently no generic version of sotorasibu on the Indian market, so patients cannot obtain the drug through Indian channels. Sotorasibu has not yet been approved for marketing in China, which means that domestic patients cannot directly purchase the original drug through formal channels. For patients who urgently need the drug, overseas channels have become the main way to obtain the drug.

In overseas markets, the original drug of sotorasibu mainly includes the European version and the Hong Kong version. These original drugs are expensive, most of them cost tens of thousands of yuan, which puts a heavy financial burden on domestic patients. In addition, the supply of original drugs is also limited. Most of the purchase channels are through overseas hospitals, international pharmacies or official import platforms. Legal prescriptions and complete purchase procedures are required to ensure the authenticity and effectiveness of the drugs.

In comparison, the prices of generic drugs that have been launched overseas are more affordable. For example, the price of generic drugs in Laos has been reduced in recent years. The price of 120mg*56 tablets is only more than 1,000 yuan. On the Laos market, there are mainly generic drugs of sotorasibu produced by two companies, Lucius and Daxiong. Its pharmaceutical ingredients are basically the same as those of the original drug, and its clinical effects can theoretically maintain similar efficacy. This provides more options for patients with limited financial resources while easing drug accessibility issues.

In terms of purchasing channels and safety, patients need to pay special attention to the formality of the channels when choosing overseas drugs. It is recommended to obtain drugs through qualified overseas pharmacies or certified cross-border medical service platforms, and ensure that complete prescriptions, drug instructions and transportation certificates are attached. Do not purchase through informal channels or personal purchasing agents to avoid drug quality risks. Obtaining drugs through legal channels and combining them with doctors' medication guidance can ensure the efficacy while reducing the risks of use and achieving safe and standardized treatment management.

Reference link:https://www.drugs.com